期刊文献+

TB-IGRA与TST检测菌培阳性肺结核患者比较 被引量:16

Diagnostic applications of TB-IGRA and TST in patients with culture-positive tuberculosis
下载PDF
导出
摘要 目的比较结核分枝杆菌γ-干扰素体外释放试验(TB-IGRA)与结核菌素皮肤试验(TST)在临床上用于检测MTB感染者的应用价值。方法 TB-IGRA与TST平行检测对147例菌培阳性肺结核患者,并分析年龄、性别和是否接种卡介苗对各自检测性能的影响。TST分别比较红肿硬块直径≥5mm(TST5)和≥15mm(TST15)者。结果 TB-IGRA和TST5的检出率分别为80.3%(118/147)和78.2%(115/147),均显著高于TST15的44.2%(65/147)。TB-IGRA在60岁以下年龄组的检出率显著高于60岁以上年龄组,TST15检出率随年龄变化趋势与TB-IGRA类似。是否接种卡介苗对TB-IGRA和TST15没有明显影响,而TST5在接种过卡介苗的患者中的阳性率显著高于未接种组。结论 TB-IGRA比TST有更高的检测灵敏度,可以作为判断结核分枝杆菌感染的手段之一。 The aim was to evaluate the clinical value on detecting Mycobacteriurn tuberculosis (MTB) of interferon-gam- ma release assay (TB-IGRA) comparing with tuberculin skin test (TST). Total of 147 cases of culture-positive tuberculosis pa- tients were parallelly detected with TB-IGRA and TST, and the influence on their performance of age, sex and BCG vaccination were analyzed. TST was evaluated with two different criteria, diameter of swelling lumps ≥ 5mm (TSTs) and ≥ 15mm (TSTla) respectively. Results indicated that the positive rates of TB-IGRA and TST5 were 80. 30% (118/147) and 78. 20% (115/147) respectively, and significantly higher than 44.2G of TST1s (65/147). The positive rate of TB-IGRA in patients be- low 60-year-old was significantly higher than those above 60-year-old, and that was observed in the results of TSTls. Vaccina- tion of BCG had no influence on the preformation of TB-IGRA and TST15, but the positive rate of TST5 was significantly higher in vaccinated group than in non-vaccinated group. In conclusion,TB-IGRA has higher sensitivity than TST, and could be used as one of the means to detect the MTB infection.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2012年第5期464-466,共3页 Chinese Journal of Zoonoses
基金 国家十一五科技重大专项资助项目(2008ZX10003-004) 福建省自然科学基金(2009-51) 厦科发计(2009-15) 厦卫科教中医(2009-627)联合资助
关键词 结核 皮肤试验 Γ-干扰素 体外释放试验 tuberculosis tuberculin skin test interferon-gammal in vitro release assay
  • 相关文献

参考文献8

  • 1Dye C, Scheele S, Dolin P,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project[J]. JAMA, 1999, 282(7): 677-686.
  • 2Richeldi L. An update on the diagnosis of tuberculosis infection [J]. American journal of respiratory and critical care medicine, 2006, 174(7):736.
  • 3肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70-74. 被引量:2850
  • 4Mazurek G H, Jereb J, Lobue P,et al. Guidelines for using the OuantiFERON-TB Gold test for detecting Mycobacterium tuber- culosis infection, United States [J ]. MMWR Recomm Rep, 2005, 54(RR-15): 49-55.
  • 5Wagstaff a J, Zellweger J P. T-SPOT. TB: an in vitro diagnostic assay measuring T cell reaction to Mycobacterium tuberculosis specific antigens[J]. Mol Diagn Ther, 2006, 10(1) : 57-63;dis- cussion 64-55.
  • 6Connell T G, Rangaka M X, Curtis N,et al. QuantiFERON-TB Gold, state of the art for the diagnosis of tuberculosis infection? [J]. Expert Review of Molecular Diagnostics, 2006, 6(5) :663- 677.
  • 7Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research[J]. Ann Intern Med, 2007, 146(5) : 340-354.
  • 8Mori T, Harada N, Higuchi K, et al. Waning of the specific in- terferon-gamma response after years of tuberculosis infection[J]. Int J Tubere Lung Dis, 2007, 11(9):1021-1025.

共引文献2849

同被引文献181

引证文献16

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部